Skip to content
Open access

FORMULATION AND IN VITRO, IN VIVO EVALUATION OF BUCCAL DRUG DELIVERY SYSTEM OF TIZANIDINE HCL

Sep 2026 · Genetics and Molecular Research · 0 citations · 5 references

TL;DR

The buccal tablets of Tizanidine HCL showed enhanced BA a which was confirmed by in-vivo studies, and may be due to the hydrophilicity a water uptake by the tablet a were considered as optimized formulation.

Abstract

Bio-adhesive buccal-delivery of drugs is one of alternative to the oral route of drug administration, particularly drugs that are having poor-bioavailability (BA) a first pass effect. The bioavailability of such drugs may be significantly improved if delivered through the buccal route. Tizanidine HCL is used widely for treating hypertension. The drug is well absorbed from the gastrointestinal tract but its bioavailability is low (30- 50%) due to extensive first pass metabolism. Since the buccal route bypasses the first-pass effect, the dose of Tizanidine HCL could be reduced by 50%. The physicochemical properties of Tizanidine HCL, its suitable half-life (3-7 h) a low molecular weight (196.64) used the oral route for small dose. Tizanidine HCL buccal muco-adhesive tablets were prepared by direct compression technique, using carbopol 934P, HPMC K4M as muco-adhesive polymers. Prepared formulations were evaluated for physicochemical characteristics, ex vivo residence time a in-vitro release studies. Further, in vivo pharmacokinetic studies were performed in pigs. The results of all the prepared tablets were within the acceptable pharmacopeial limits. The swelling a bio-adhesive strength values were increased a drug-release (DR) was decreased with increasing the polymer concentration. From the results, tablets with Na CMC (F2) exhibited better release, which may be due to the hydrophilicity a water uptake by the tablet a were considered as optimized formulation. The optimized formulation F2 developed with HPMC K4M released 99.62±2.24% in 6 h. The release mechanism from kinetic methods suggests that, the drug-release (DR) follows zero-order kinetics with diffusion mechanism. The drug permeation was fou to be 89.88%, while the flux a permeability coefficient of Tizanidine HCL was calculated to be 0.668 mg h−1 cm−2 a 0.056 cm h−1, respectively.  DSC studies confirming that there was no interaction between the drug and other excipients.3.09-folds enhance bio-adhesive in the oral bioavailability (BA) of Tizanidine HCL from buccal tablet when compared with immediate release marketed formulation (Nepresol®). Thus, the buccal tablets of Tizanidine HCL showed enhanced BA a which was confirmed by in-vivo studies.

Read PDF

Similar papers

Review Oct 2026

Design and Evaluation of Buccal Bioadhesive Films for Improved Bioavailability of a First-Pass Metabolized Drug: A Review

Buccal bioadhesive films represent an important mucoadhesive platform for improving systemic exposure of drugs that undergo extensive gastrointestinal degradation or hepatic first-pass metabolism. Conventional oral dosage forms remain the dominant route of drug administration because they are convenient, economical and...

Rishikesh Yadav, Lata Choudhary, Y. Pounikar et al. · 0 citations
Oct 2026

Formulation and Optimization of Cilnidipine Nanoparticle-loaded Mucoadhesive Buccal Tablets using Quality by Design Approach for Enhanced Systemic Bioavailability

Cilnidipine, a calcium channel blocker used to treat hypertension, has poor oral bioavailability owing to extensive first-pass intestinal and hepatic metabolism. Buccal delivery offers an alternative route that bypasses hepatic first-pass metabolism and provides controlled systemic absorption. This study aimed to f...

Mahallingan K, Vedamurthy Joshi · 0 citations
Open access Oct 2026

Formulation and Evaluation of Mucoadhesive Buccal Patch of Clomipramine Hydrochloride for Enhanced Buccal Drug Delivery

Background: Mucoadhesive buccal patches are being investigated as alternatives to conventional oral dosage forms for drugs affected by hepatic first-pass metabolism. Objective: This study aimed to formulate and evaluate clomipramine hydrochloride buccal patches using hydroxypropyl methylcellulose (HPMC E15) and Carbopo...

B. Kousalya, A. Selvi · 0 citations
Open access 2026

Formulation by Ether Injection Method and In-Vitro, In-Vivo Evaluation of Tween 80 Based Metformin Loaded Niosomes: A Smart Strategy in the Drug Delivery System

Metformin hydrochloride is one of the first-line oral antidiabetics but because of low oral bioavailability and biological half-life, there is need for formulation of more advanced drug delivery systems for this drug. In this study, niosomes loaded with metformin were formulated by the use of ether injection technique...

M. M. Alam, Fahamida Binta Anower, Kazi Nadia Haque Sharna et al. · 0 citations
Open access Oct 2026

Design, Characterization and Evaluation of Transdermal Patches of Zaltoprofen

The oral route of administering drugs has several drawbacks, such as limited bioavailabilitydue to to hepatic first-pass metabolism and a tendency to generate rapid, either high or low blood level spikes. In the current study, transdermal administration of Zaltoprofen was designed to circumvent first pass metabolism an...

Neeraja Podichety, Naveen Jamjala, Anitha Bandi et al. · 0 citations
Oct 2026

Design and Evaluation of Buccal Bioadhesive Films for Improved Bioavailability of a First-Pass Metabolized Drug

Buccal bioadhesive films are increasingly investigated as patient-friendly orotransmucosal dosage forms for drugs that undergo extensive first-pass metabolism after oral administration. This paper presents a formulation-oriented research design for propranolol hydrochloride as a model first-pass metabolized drug. The o...

Lata Choudhary, S. Sahu, Mohammad Akhtar Rasool et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.